Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Beasley DW"'
Autor:
Johnson DM; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Brasel T; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, Texas, USA., Massey S; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, Texas, USA., Smith J; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, Texas, USA., Garron T; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Wallace S; Experimental Pathology Laboratories Inc., Sterling, Virginia, USA., Yu X; Department of Biostatistics & Data Science, University of Texas Medical Branch, Galveston, Texas, USA., Beasley DW; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, Texas, USA., Comer JE; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, Texas, USA.
Publikováno v:
Journal of virology [J Virol] 2023 May 31; Vol. 97 (5), pp. e0188822. Date of Electronic Publication: 2023 Mar 28.
Autor:
Johnson DM; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Brasel T; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Massey S; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Garron T; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Grimes M; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Smith J; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Torres M; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Wallace S; Experimental Pathology Laboratories Inc., Sterling, VA, USA., Villasante-Tezanos A; Department of Biostatistics and Data Science, University of Texas Medical Branch, Galveston, TX, USA., Beasley DW; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Comer JE; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: jscomer@utmb.edu.
Publikováno v:
Antiviral research [Antiviral Res] 2023 Jan; Vol. 209, pp. 105492. Date of Electronic Publication: 2022 Dec 16.
Autor:
Comer JE; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Brasel T; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Massey S; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Beasley DW; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Cirimotich CM; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA., Sanford DC; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA., Chou YL; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA., Niemuth NA; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA., Novak J; AmplifyBio, West Jefferson, OH 43162, USA., Sabourin CL; Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Merchlinsky M; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Long JP; Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Stavale EJ; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Wolfe DN; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA.
Publikováno v:
Viruses [Viruses] 2022 Oct 18; Vol. 14 (10). Date of Electronic Publication: 2022 Oct 18.
Autor:
Reece LM; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA., Beasley DW; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA; Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Milligan GN; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA., Sarathy VV; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA., Barrett AD; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: abarrett@utmb.edu.
Publikováno v:
Current opinion in virology [Curr Opin Virol] 2018 Apr; Vol. 29, pp. 72-78. Date of Electronic Publication: 2018 Apr 09.
Autor:
Koma T; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA.; Department of Microbiology, Tokushima University Graduate School of Medical Science, Tokushima, Japan., Veljkovic V; Biomed Protection, Galveston, Texas, USA., Anderson DE; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Wang LF; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore., Rossi SL; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA., Shan C; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA., Shi PY; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.; Institute for Translational Science, University of Texas Medical Branch, Galveston, Texas, USA.; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, Texas, USA.; Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, Texas, USA., Beasley DW; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA., Bukreyeva N; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA., Smith JN; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA., Hallam S; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA., Huang C; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA., von Messling V; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore.; Veterinary Medicine Division, Paul-Ehrlich-Institute, Langen, Germany., Paessler S; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA. slpaessl@utmb.edu.; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA. slpaessl@utmb.edu.
Publikováno v:
Scientific reports [Sci Rep] 2018 Jan 30; Vol. 8 (1), pp. 1882. Date of Electronic Publication: 2018 Jan 30.
Autor:
Dawes BE; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Smalley CA; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA., Tiner BL; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Beasley DW; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, USA.; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX, USA., Milligan GN; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, USA.; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.; Department of Pediatrics, University of Texas Medical Branch, Galveston, TX, USA., Reece LM; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, USA.; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA., Hombach J; Initiative for Vaccine Research, Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland., Barrett AD; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.; Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, TX, USA.; World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX, USA.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2016 Jul 28; Vol. 1, pp. 16007. Date of Electronic Publication: 2016 Jul 28 (Print Publication: 2016).
Autor:
Friedrich BM; Department of Microbiology and Immunology, Sealy Center for Vaccine Development, Institute for Human Infections and Immunity, University of Texas Medical Branch, MRB, Route 0609, 301 University Blvd., Galveston, TX, USA., Beasley DW; Department of Microbiology and Immunology, Sealy Center for Vaccine Development, Institute for Human Infections and Immunity, University of Texas Medical Branch, Keiller Building, Route 0609, 301 University Blvd., Galveston, TX, USA. dwbeasle@utmb.edu.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2016; Vol. 1435, pp. 129-41.
Autor:
McAuley AJ; Department of Microbiology and Immunology, Sealy Center for Vaccine Development, Institute for Human Infections and Immunity, University of Texas Medical Branch, Keiller Building, Route 0609, 301 University Blvd., Galveston, TX, USA., Beasley DW; Department of Microbiology and Immunology, Sealy Center for Vaccine Development, Institute for Human Infections and Immunity, University of Texas Medical Branch, Keiller Building, Route 0609, 301 University Blvd., Galveston, TX, USA. dwbeasle@utmb.edu.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2016; Vol. 1435, pp. 19-27.
Autor:
Erasmus JH; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, United States of America; Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America., Needham J; InBios International, Inc., Seattle, Washington, United States of America., Raychaudhuri S; InBios International, Inc., Seattle, Washington, United States of America., Diamond MS; Departments of Medicine, Molecular Microbiology, Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, United States of America., Beasley DW; Institute for Human Infections and Immunity, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America; Center for Biodefense and Emerging Infectious Diseases, and Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas, United States of America., Morkowski S; InBios International, Inc., Seattle, Washington, United States of America., Salje H; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Pasteur Institute, Paris, France., Fernandez Salas I; Centro Regional de Investigación en Salud Publica INSP. Tapachula, Chiapas, Mexico., Kim DY; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America., Frolov I; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America., Nasar F; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, United States of America; Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America., Weaver SC; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, Texas, United States of America; Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America; Institute for Human Infections and Immunity, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Publikováno v:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2015 Oct 22; Vol. 9 (10), pp. e0004119. Date of Electronic Publication: 2015 Oct 22 (Print Publication: 2015).
Autor:
Liu G; VaxInnate Corporation, Cranbury, New Jersey, USA ge.liu@vaxinnate.com., Song L; VaxInnate Corporation, Cranbury, New Jersey, USA., Beasley DW; Department of Microbiology and Immunology, Sealy Center for Vaccine Development, and Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA., Putnak R; Viral Disease Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA., Parent J; VaxInnate Corporation, Cranbury, New Jersey, USA., Misczak J; VaxInnate Corporation, Cranbury, New Jersey, USA., Li H; VaxInnate Corporation, Cranbury, New Jersey, USA., Reiserova L; VaxInnate Corporation, Cranbury, New Jersey, USA., Liu X; VaxInnate Corporation, Cranbury, New Jersey, USA., Tian H; VaxInnate Corporation, Cranbury, New Jersey, USA., Liu W; VaxInnate Corporation, Cranbury, New Jersey, USA., Labonte D; VaxInnate Corporation, Cranbury, New Jersey, USA., Duan L; VaxInnate Corporation, Cranbury, New Jersey, USA., Kim Y; VaxInnate Corporation, Cranbury, New Jersey, USA., Travalent L; VaxInnate Corporation, Cranbury, New Jersey, USA., Wigington D; VaxInnate Corporation, Cranbury, New Jersey, USA., Weaver B; VaxInnate Corporation, Cranbury, New Jersey, USA., Tussey L; VaxInnate Corporation, Cranbury, New Jersey, USA.
Publikováno v:
Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2015 May; Vol. 22 (5), pp. 516-25. Date of Electronic Publication: 2015 Mar 11.